Skip to main content
. 2017 Apr 12;6(5):e1312239. doi: 10.1080/2162402X.2017.1312239

Figure 2.

Figure 2.

Donor-derived HLA-A*02:01/CHM1319 TCR transgenic T cells specifically recognize HLA-A*02+/CHM1+ cell lines in vitro. (A) CHM1319-TCR-transgenic T cells specifically recognize CHM1319-loaded T2 cells and (B) HLA-A*02:01+/CHM1+ Ewing sarcoma cell lines A673, TC-71, and the patient-derived cell line SB-KMS-GH in contrast to HLA-A*02:01/CHM1+ SK-NMC, K562, and SB-KMS-KS1 control cell lines in IFNγ ELISpot assays. The E/T ratio for ELISpot assay was 1:4. Error bars represent standard deviation of triplicate experiments. Asterisks indicate significance levels.